Search Results - "van Dreden, P."

Acquired chemoresistance of colorectal cancer (CRC) cells is accompanied by pro-invasive VEGF-signaling that can be attenuated by aflibercept by Larsen, A.K., van Dreden, P., Chibaudel, B., de Gramont, A., Gerotziafas, G., Thouroude, S.

Get full text

Transient Factor V deficiency associated with Factor V-immunoglobulin complexes but without evidence of a classical inhibitor by Cortier, D, Van Dreden, P, Adam, M, Bironien, R, François, D, Vasse, M

Get full text

Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women by Conard, J, Horellou, M H, Van Dreden, P, Lecompte, T, Samama, M

Get more information

OC-3b: Increased baseline TF activity in women with unexplained pregnancy loss: an additional argument for a basal endothelial dysfunction? by Pasquier, E, Van Dreden, P, Rousseau, A, de Saint Martin, L, Mottier, D, Couturaud, F

Get full text

OC-03 - Modelisation of the procoagulant properties of cancer cells and their capacity to alter the antithrombotic efficiency of LMWHs and specific inhibitors of factor Xa by Gerotziafas, G.T, Rousseau, A, van Dreden, P, Mbemba, E, Gkalea, V, Khaterchi, A, Larsen, A, Elalamy, I

“…Introduction The risk of venous thromboembolism varies according to the histological type of cancer. The failure of antithrombotic treatment is more frequent…”
Get full text

C0202: Decreased Levels of Procoagulant Phospholipids in Bleeding Patients with Overcoagulation by Vitamin K Antagonists by Van Dreden, P, Mathieu, E, Grusse, M, François, D, Vasse, M

Get full text

Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia by Filhon, B, Dumesnil, C, Van Dreden, P, Schneider, P, Vasse, M, Vannier, J.P

Get full text

PO-53 - Prospective evaluation of risk assessment models and biological markers of hypercoagulability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study by Boura, P, Evmorfiadis, I, Rousseau, A, Charpidou, A, Giozos, G, Van Dreden, P, Syrigos, K, Larsen, A, Elalamy, I, Gerotziafas, G.T

“…Introduction In patients with lung adenocarcinoma (LA), metastasis (MTS), advanced stage and chemotherapy (CTx) are risk factors for thromboembolism (VTE)…”
Get full text

Total and free levels of tissue factor pathway inhibitor: a risk factor in patients with factor V Leiden? by Van Dreden, P, Grosley, M, Cost, H

Get more information

C0531: Impact of Thrombin Generation, Tissue Factor Activity and Thrombomodulin Activity on the Positivity of Assisted Reproductive Technique in Infertile Women by Mathieu d’Argent, E, Van Dreden, P, Comtet, M, Gkalea, V, Ketatni, H, Antoine, J.-M, Bouffard, S, Rousseau, A, Lefkou, E, Elalamy, I, Gerotziafas, G

Get full text

Impact of lobectomy on hypercoagulable state in patients with primary adenocarcinoma of the lung by Papageorgiou, C, Van Dreden, P, Marret, E, Bonnet, F, Woodhams, B, Spyropoulos, A.C, Elalamy, I, Gerotziafas, G.T

Get full text

Variability of response of thromboprophylaxis with fixed dose of enoxaparin in patients with primary adenocarcinoma of the lung undergoing lobectomy by Papageorgiou, C, Marret, E, Van Dreden, P, Bonnet, F, Woodhams, B, Spyropoulos, A.C, Gerotziafas, G.T, Elalamy, I

Get full text

Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra®) anti‐Xa activity by Depasse, F., Gerotziafas, G. T., Busson, J., Van Dreden, P., Samama, M. M.

Get full text

Low levels of protein S activity in factor V depleted plasma used in APC resistance test by Samama, M S, Gouin-Thibault, I, Trossaert, M, Van Dreden, P, Combot, C, Amiral, J, Horellou, M H, Conard, J

Get more information

Assessment of activated protein C resistance using a new and rapid venom-based test: STA Staclot APC-R by Oger, E, Leroyer, C, Mercier, B, Van Dreden, P, Bressollette, L, De Saint-Martin, L, Le Moigne, E, Blouch, M T, Thuillier, N, Amiral, J, Ferec, C, Abgrall, J F, Mottier, D

“…Activated protein C (APC) resistance is related to a single point mutation in the factor V gene (FV:Q506) and appears to be the most common inherited risk…”
Get more information

PO-71 Detection of procoagulant phospholipids in plasma from patients with thyroid cancer by Woodhams, B, Rousseau, A, Fontaine, S, Van Dreden, P

Get full text

PB1204 Synergistic Role in Accelerating Clot Formation and Fibrin Polymerisation of Cancer Cells and Platelets: a Thromboelastometric Study by Mbemba, E., Van Dreden, P., Gerotziafas, G.

Get full text

1875PAcquired chemoresistance of colorectal cancer (CRC) cells is accompanied by pro-invasive VEGF-signaling that can be attenuated by aflibercept by Larsen, A K, van Dreden, P, Chibaudel, B, de Gramont, A, Gerotziafas, G, Thouroude, S

Get full text

PB0054 Impact of Variations in Sex Hormone Levels on the Hypercoagulability and Severity of COVID-19 in Women and Men According to Age. The ROADMAP-COVID-19 Study by Van Dreden, P., Sabbah, M., Grussé, M., Rousseau, A., Louadj, L., Gerotziafas, G.

Get full text

PB0973 Perioperative Coagulation Profile in Major Liver Resection for Cancer by Lefkou, E., Tzimas, P., Van Dreden, P., Karakosta, A., Papapetrou, E., Pantazi, D., Stratigopoulou, P., Gerotziafas, G.

Get full text